Investigation of resveratrol as a xanthine oxidase inhibitor: Mechanistic insights and therapeutic implications for gout and hyperuricemia
Biotechnology and Applied Biochemistry · 2025
DOI: 10.1002/bab.2690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2025. Verfasst von Jianmin Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Putian University, Fujian, China. Hauptthemen laut MEDLINE: Resveratrol, Xanthine Oxidase, Hyperuricemia, Gout. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Research Projects of Putian University, National Natural Science Foundation of China, Science and Technology Bureau of Putian City.
Abstract (Originalsprache)
Gout predominantly stems from hyperuricemia, precipitating the accumulation of urate crystals and consequent joint inflammation, swelling, and pain, thereby compromising the quality of life and presenting a formidable medical dilemma. Although conventional treatments like allopurinol and febuxostat target uric acid reduction via xanthine oxidase (XO) inhibition, they often entail adverse effects, prompting the exploration of safer alternatives. Resveratrol, a polyphenolic compound abundant in fruits and vegetables, has emerged as a potential XO inhibitor. However, its precise inhibitory mechanisms remain poorly understood. This study aims to comprehensively investigate resveratrol's XO inhibition through mechanistic insights, molecular docking simulations, animal model experiments, and biochemical analysis, contributing valuable insights to the development of novel therapeutics for hyperuricemia and gout.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Putian University, Fujian, China.
- Key Laboratory of Pharmaceutical Analysis and Laboratory Medicine (Putian University), Fujian Province University, Fujian, China.
ORCID-Profile: Jianmin Chen
Förderung
- Research Projects of Putian University
- National Natural Science Foundation of China
- Science and Technology Bureau of Putian City
Zitieren
APA
Chen, J., Chen, J., Feng, B., Ning, M., Wu, W., & Zou, S. (2025). Investigation of resveratrol as a xanthine oxidase inhibitor: Mechanistic insights and therapeutic implications for gout and hyperuricemia. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2690
Vancouver
Chen J, Chen J, Feng B, Ning M, Wu W, Zou S. Investigation of resveratrol as a xanthine oxidase inhibitor: Mechanistic insights and therapeutic implications for gout and hyperuricemia. Biotechnology and Applied Biochemistry. 2025. doi:10.1002/bab.2690
BibTeX
@article{Chen2025,
author = {Chen, Jianmin and Chen, Juan and Feng, Baozhu and Ning, Meilian and Wu, Wanhui and Zou, Shiqi},
title = {Investigation of resveratrol as a xanthine oxidase inhibitor: Mechanistic insights and therapeutic implications for gout and hyperuricemia},
journal = {Biotechnology and Applied Biochemistry},
year = {2025},
doi = {10.1002/bab.2690}
}
EUVIMED